Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Postgraduate Medicine
|
November 15, 2015
Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations
Maciej Gasior, Mary Bond, Richard Malamut
Journal of Opioid Management
|
May 20, 2016
Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential
Martin E Hale, Yuju Ma, Richard Malamut
Cleveland Clinic Journal of Medicine
|
June 3, 2005
Diabetic retinopathy: treating systemic conditions aggressively can save sight
Stephen H Sinclair, Richard Malamut, Cherie Delvecchio, et al.
Journal of Opioid Management
|
January 6, 2016
Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain
Martin E Hale, Thomas R Zimmerman, Eli Eyal, et al.
Pain Practice : the Official Journal of World Institute of Pain
|
February 10, 2016
Evaluation of Quality of Life, Functioning, Disability, and Work/School Productivity Following Treatment with an Extended-Release Hydrocodone Tablet Formulated with Abuse-Deterrence Technology: A 12-month Open-label Study in Patients with Chronic Pain
Martin E Hale, Thomas R Zimmerman, Yuju Ma, et al.
Journal of Opioid Management
|
November 5, 2015
Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain
Martin E Hale, Thomas R Zimmerman, Yuju Ma, et al.
Journal of Pain Research
|
September 24, 2015
Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain
Martin E Hale, Charles Laudadio, Ronghua Yang, et al.
Pain Management
|
April 7, 2016
Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain
Martin E Hale, Derek Moe, Mary Bond, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
November 3, 2011
The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale
Horacio Kaufmann, Richard Malamut, Lucy Norcliffe-Kaufmann, et al.
Muscle & Nerve
|
July 9, 2005
Usefulness of electrodiagnostic techniques in the evaluation of suspected tarsal tunnel syndrome: an evidence-based review
Atul T Patel, Kenneth Gaines, Richard Malamut, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Postgraduate Medicine
|
November 15, 2015
Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations
Maciej Gasior, Mary Bond, Richard Malamut
Journal of Opioid Management
|
May 20, 2016
Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential
Martin E Hale, Yuju Ma, Richard Malamut
Cleveland Clinic Journal of Medicine
|
June 3, 2005
Diabetic retinopathy: treating systemic conditions aggressively can save sight
Stephen H Sinclair, Richard Malamut, Cherie Delvecchio, et al.
Journal of Opioid Management
|
January 6, 2016
Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain
Martin E Hale, Thomas R Zimmerman, Eli Eyal, et al.
Pain Practice : the Official Journal of World Institute of Pain
|
February 10, 2016
Evaluation of Quality of Life, Functioning, Disability, and Work/School Productivity Following Treatment with an Extended-Release Hydrocodone Tablet Formulated with Abuse-Deterrence Technology: A 12-month Open-label Study in Patients with Chronic Pain
Martin E Hale, Thomas R Zimmerman, Yuju Ma, et al.
Journal of Opioid Management
|
November 5, 2015
Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain
Martin E Hale, Thomas R Zimmerman, Yuju Ma, et al.
Journal of Pain Research
|
September 24, 2015
Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain
Martin E Hale, Charles Laudadio, Ronghua Yang, et al.
Pain Management
|
April 7, 2016
Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain
Martin E Hale, Derek Moe, Mary Bond, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
November 3, 2011
The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale
Horacio Kaufmann, Richard Malamut, Lucy Norcliffe-Kaufmann, et al.
Muscle & Nerve
|
July 9, 2005
Usefulness of electrodiagnostic techniques in the evaluation of suspected tarsal tunnel syndrome: an evidence-based review
Atul T Patel, Kenneth Gaines, Richard Malamut, et al.
Page
of 3